Continuous Positive Airway Pressure

Excessive daytime sleepiness is a common symptom of several sleep disorders, including obstructive sleep apnea, which is estimated to affect 10% to 30% of adults in the U.S and often goes underdiagnosed, according to the Sleep Foundation.

Adults with obstructive sleep apnea faced elevated risks for developing COVID-19 and experiencing COVID-19-related complications, according to study results published in Thorax.

The risk for major adverse cardiovascular events among patients with sleep apnea who used positive airway pressure for at least 6 hours a night was lower than among those who used it for less time, according to study results.

A drug administered through a nasal spray may be an alternative treatment option for patients with obstructive sleep apnea by improving upper airway collapsibility, according to a study published in CHEST.

The FDA has granted 510(k) clearance to a daytime-nighttime appliance, or DNA, to treat patients with mild to moderate obstructive sleep apnea, according to a manufacturer-issued press release.

New data have linked more consistent use of CPAP treatment to lower risk for rehospitalization in older adults with obstructive sleep apnea and cardiovascular disease.

Air pollution concentrations, even at relatively low levels, were associated with a change in the effectiveness of positive airway pressure therapy among individuals with obstructive sleep apnea, according to findings published in Chest.

A 3-month telemonitoring and coaching program resulted in immediate short-term improvements in CPAP adherence, but failed to lead to sustained improvements over time, researchers reported.

Most patients with obstructive sleep apnea retained their metabolic syndrome diagnosis after CPAP therapy, despite higher rates of reversibility after treatment, according to findings of a randomized trial published in Chest.

Ongoing continuous positive airway pressure use in the first year after starting therapy was associated with lower risk for all-cause mortality in patients with obstructive sleep apnea, according to research published in Chest.